U.S., Europe, and Japan Adhesion Barriers Market

Q: What will be the CAGR of the U.S., Europe, and Japan adhesion barriers industry during the forecast period?

The CAGR is anticipated to be 6.0% from 2025 to 2035. Read More

U.S., Europe, and Japan Adhesion Barriers Market (Product Type: Seprafilm, Gynecare Interceed, Adept, Duragen Plus, MediShield, Oxiplex, 4DryField PH, Hyalobarrier, Tenaleaf, Adspray and Others; and Formulation: Film, Gel and Liquid; Application: Gynecological Surgery, Abdominal Surgery, Neuro Surgery, Orthopedic Surgery and Others) - Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035

U.S., Europe, and Japan Adhesion Barriers Market Outlook 2035

The U.S., Europe and Japan industry was valued at US$ 1.3 Bn in 2024
It is projected to grow at a CAGR of 6.0% from 2025 to 2035 and cross US$ 2.4 Bn by the end of 2035

Analysts’ Viewpoint

The U.S., Europe and Japan adhesion barriers market driven by the increasing volume of surgical procedures - particularly in abdominal, orthopedic, cardiovascular, and gynecological surgeries - and the increasing awareness among surgeons and healthcare providers of complications due to postoperative adhesion.

Us Europe And Japan Adhesion Barriers Market Revenue Growth (US$ Bn)

The U.S. market is expected to gain more traction due to R&D investment, established early adopters of superior surgical technologies, and a high-volume surgery market. Europe is demonstrated to have a growing rate of demand due to an aging population, increased chronic disease prevalence, and expected changes in surgical prevalence of minimally invasive and laparoscopic surgeries.

While Japan is on a positive growth path impeded only by intense demographic trends, high expectations regarding surgical standards and favorable increases in healthcare spending, it nonetheless offers additional and lucrative growth opportunities.

U.S., Europe, and Japan Adhesion Barriers Market Introduction

Adhesion barriers imply medical devices or materials used for preventing or reducing the formation of adhesions, which are bands of fibrous tissue that can form between organs or an organ and the wall of the abdomen. Adhesions can occur as a result of surgery, injury, or disease, and could lead to complications such as bowel obstruction, chronic pain, and infertility.

Attribute	Detail
U.S., Europe, and Japan Adhesion Barriers Market Drivers	Increasing Number of Surgical Procedures Technological Advancements in Adhesion Barrier Products

Increasing Number of Surgical Procedures Anticipated to Boost U.S., Europe, and Japan Adhesion Barriers Market Share

Rise in the number of surgical procedures in the U.S., Europe, and Japan is driving the growth of the adhesion barriers market in these regions. The aging population and rising incidences of chronic conditions are driving the demand for surgery, especially around gynecology, cardiovascular, abdominal, and orthopedics procedures.

Research states that in January 2025 there were 895,606 gastroenterological and abdominal surgical procedures registered in the National Clinical Database (NCD) in Japan in 2023.

According to data published by European Union in July 2024, there were over 1.10 million caesarean sections performed in the EU in 2022.

Moreover, according to an article published by NCBI in 2020, a staggering 310 million major surgeries are performed each year across the globe; with around 40 to 50 million in U.S. and 20 million in Europe.

Adhesion barriers, which are applied during surgery to minimize the risk of internal scar tissue formation, are thus being adopted more widely as a part of standard surgical protocols.

Technological Advancements in Adhesion Barrier Products to Drive U.S., Europe, and Japan Adhesion Barriers Market Expansion

The technological advancements in adhesion barrier products are significantly propelling the growth of the U.S., Europe, and Japan adhesion barriers industry. Innovations have introduced biocompatible and biodegradable materials and include advanced forms such as gels and sprayable solutions.

Biocompatible and biodegradable products have also increased the effectiveness and safety of those products, which promotes interest from a range of healthcare professionals, and increased patient use.

With the emergence of bioresorbable polymers and hydrogels, these barriers will dissolve naturally in the body, limiting the need for follow-up procedures and potentially reducing long-term adverse complications, which improves patient outcomes and encourages adoption.

Furthermore, new delivery mechanisms such as spray applicators and ready-to-use applicators have eased the application process, allowing adhesion barrier usage for a greater diversity of surgical approaches, also including minimally invasive and robotic surgery.

In developed markets there are also increasing regulatory approvals and progressive reimbursement policies, which further accelerate the market penetration

Seprafilm Leading U.S., Europe, and Japan Adhesion Barriers Market

Seprafilm is the leading product type segment in the U.S., Europe, and Japan adhesion barrier market based on years of clinical use, regulatory approvals and demonstrated efficacy in decreasing postoperative adhesions.

Its widespread use in open and laparoscopic procedures, preference by surgeons, and a robust clinical literature base have established it as the leading product in the market in key global regions. In Japan and Europe (where regulations are considerably strict and sustained), growth occurs with Seprafilm due to performance and safety profile. The awareness of complications associated with adhesion in the healthcare community continues to rise. Seprafilm remains the gold standard in the adhesion barrier market.

Region/Country Outlook of the U.S., Europe, and Japan Adhesion Barriers Market

Attribute	Detail
Leading Country	U.S.

An increasing number of surgical procedures within gynecological and abdominal specialties are likely to increase the number of surgical procedures in the U.S.

The aging of the population and increase in incidences of chronic diseases are leading to increasing surgical volumes, which will ultimately lead to increased demand for these products. The U.S. is positioned as a leader in the U.S., Europe, and Japan adhesion barriers market, which is further enhanced by the presence of leading medical device companies and focus on patient satisfaction and outcomes.

Analysis of Key Players in U.S., Europe, and Japan Adhesion Barriers Market

Baxter International Inc., Terumo Medical Corporation, Medtronic plc, Johnson & Johnson Services, Inc., Integra LifeScience, PlantTec Medical GmbH, Fziomed, Inc., Anika Therapeutics, Inc., Kyeron, BioRegen Biomedical (Changzhou) Co., Ltd, DALIM TISSEN Co., Ltd., and Gunze Medical Co., Ltd. are some of the leading players operating in the U.S., Europe, and Japan adhesion barriers market.

Each of these players has been have been profiled in the U.S., Europe, and Japan Adhesion Barriers Market research report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

Key Developments in the U.S., Europe, and Japan Adhesion Barriers Market

In March 2025, Fziomed, Inc. announced that it would attend the 2025 IFSSH and IFSHT Triennial Global Hand Congress March 24-28, 2025 in Washington, D.C., U.S. hosted by the American Society for Surgery of the Hand, American Society of Hand Therapists, and American Association for Hand Surgery. The company will showcase its Dynavisc Adhesion Barrier Gel, the only synthetic dual-polymer technology on the market, designed to reduce adhesion formation following tendon and peripheral nerve surgery.
In July 2023, Seikagaku Corporation announced that favorable results were obtained in a pivotal study in Japan for SI-449, a surgical adhesion barrier, in the field of gastroenterological surgery. The study was a randomized study in patients who underwent open proctectomy.

U.S., Europe, and Japan Adhesion Barriers Market Snapshot

Attribute	Detail
Size in 2024	US$ 1.3 Bn
Forecast Value in 2035	US$ 2.4 Bn
CAGR	6.0%
Forecast Period	2025-2035
Historical Data Available for	2020-2023
Quantitative Units	US$ Bn
Adhesion Barriers Market Analysis	It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, value chain analysis, and key trend analysis.
Competition Landscape	Competition Matrix Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials
Format	Electronic (PDF) + Excel
Segmentation	Product Seprafilm Gynecare Interceed Adept Duragen Plus MediShield Oxiplex 4DryField PH Hyalobarrier Tenaleaf Adspray Others Product Type-Application Seprafilm Gynecological Surgery Abdominal Surgery Neuro Surgery Orthopedic Surgery Others Gynecare Interceed Adept Duragen Plus MediShield Oxiplex 4DryField PH Hyalobarrier Tenaleaf Adspray Others Formulation Film Seprafilm Gynecare Interceed Adept Duragen Plus MediShield Oxiplex 4DryField PH Hyalobarrier Tenaleaf Adspray Others Gel Liquid Formulation-Application Film Seprafilm Gynecare Interceed Adept Duragen Plus MediShield Oxiplex 4DryField PH Hyalobarrier Tenaleaf Adspray Others Gel Liquid Application Gynecological Surgery Abdominal Surgery Neuro Surgery Orthopedic Surgery Others End-user Ambulatory Surgical centers (ASCs) Hospitals Specialty Clinics Others
Regions Covered	U.S., Europe and Japan
Countries Covered	U.S., Europe Germany U.K. France Italy Spain Russia Rest of Europe Japan
Companies Profiled	Baxter International Inc. Terumo Medical Corporation Medtronic plc Johnson & Johnson Services, Inc. Integra LifeScience PlantTec Medical GmbH Fziomed, Inc. Anika Therapeutics, Inc. Kyeron BioRegen Biomedical (Changzhou) Co., Ltd DALIM TISSEN Co., Ltd. Gunze Medical Co., Ltd.
Customization Scope	Available upon request
Pricing	Available upon request

Frequently Asked Questions

How big was the U.S., Europe, and Japan adhesion barriers market in 2024?

The U.S., Europe, and Japan adhesion barriers market was valued at US$ 1.3 Bn in 2024.

How big will the U.S., Europe, and Japan adhesion barriers market business be in 2035?

The Middle East and U.S., Europe, and Japan adhesion barriers business is projected to reach more than US$ 2.4 Bn by the end of 2035.

What are the factors driving the U.S., Europe, and Japan adhesion barriers market?

Increasing number of surgical procedures, technological advancements in adhesion barrier products, and growing focus on post-surgical care and the prevention of complications.

What will be the CAGR of the U.S., Europe, and Japan adhesion barriers industry during the forecast period?

The CAGR is anticipated to be 6.0% from 2025 to 2035.

Who are the prominent players in the U.S., Europe and Japan adhesion barriers market?

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : U.S., Europe, and Japan Adhesion Barriers Market

4. Market Overview

4.1. Introduction

4.1.1. Segment Definition

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. U.S., Europe, and Japan Adhesion Barriers Market Analysis and Forecasts, 2020 to 2035

4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

5.1. Key Industry Events

5.2. Distributors Landscape

5.3. Value Chain Analysis

5.4. PORTER’s Five Forces Analysis

5.5. PESTLE Analysis

5.6. Go-to-Market Strategy for New Market Entrants across Key Regions / Countries

5.7. Product Volume for each Product by Country / Region (Units), 2023-2024

5.8. Average Number Units of Adhesion Barrier Products Used in One Surgery

5.9. Regulatory Scenario By Country/Region

5.10. Pricing Analysis for Each Product (US$) by Country/Region

5.10.1. By Sales

5.10.1.1. Online

5.10.1.2. Direct

5.10.2. By Purchasing Entity

5.10.2.1. Academic Hospital

5.10.2.2. Large Institution

5.10.2.3. Large Hospital

5.10.2.4. Small Hospital/Private Practitioners

6. U.S., Europe, and Japan Adhesion Barriers Market Analysis and Forecasts, By Product Type

6.1. Introduction & Definition

6.2. Key Findings / Developments

6.3. Market Value Forecast By Product Type, 2020 to 2035

6.3.1. Seprafilm

6.3.2. Gynecare Interceed

6.3.3. Adept

6.3.4. Duragen Plus

6.3.5. MediShield

6.3.6. Oxiplex

6.3.7. 4DryField PH

6.3.8. Hyalobarrier

6.3.9. Tenaleaf

6.3.10. Adspray

6.3.11. Others

6.4. Market Attractiveness By Product Type

7. U.S., Europe, and Japan Adhesion Barriers Market Analysis and Forecasts, By Product Type-Application

7.1. Introduction & Definition

7.2. Key Findings / Developments

7.3. Market Value Forecast By Product Type-Application, 2020 to 2035

7.3.1. Seprafilm

7.3.1.1. Gynecological Surgery

7.3.1.2. Abdominal Surgery

7.3.1.3. Neuro & Orthopedic Surgery

7.3.1.4. Orthopedic Surgery

7.3.1.5. Others

7.3.2. Gynecare Interceed

7.3.2.1. Gynecological Surgery

7.3.2.2. Abdominal Surgery

7.3.2.3. Neuro & Orthopedic Surgery

7.3.2.4. Orthopedic Surgery

7.3.2.5. Others

7.3.3. Adept

7.3.3.1. Gynecological Surgery

7.3.3.2. Abdominal Surgery

7.3.3.3. Neuro & Orthopedic Surgery

7.3.3.4. Orthopedic Surgery

7.3.3.5. Others

7.3.4. Duragen Plus

7.3.4.1. Gynecological Surgery

7.3.4.2. Abdominal Surgery

7.3.4.3. Neuro & Orthopedic Surgery

7.3.4.4. Orthopedic Surgery

7.3.4.5. Others

7.3.5. MediShield

7.3.5.1. Gynecological Surgery

7.3.5.2. Abdominal Surgery

7.3.5.3. Neuro & Orthopedic Surgery

7.3.5.4. Orthopedic Surgery

7.3.5.5. Others

7.3.6. Oxiplex

7.3.6.1. Gynecological Surgery

7.3.6.2. Abdominal Surgery

7.3.6.3. Neuro & Orthopedic Surgery

7.3.6.4. Orthopedic Surgery

7.3.6.5. Others

7.3.7. 4DryField PH

7.3.7.1. Gynecological Surgery

7.3.7.2. Abdominal Surgery

7.3.7.3. Neuro & Orthopedic Surgery

7.3.7.4. Orthopedic Surgery

7.3.7.5. Others

7.3.8. Hyalobarrier

7.3.8.1. Gynecological Surgery

7.3.8.2. Abdominal Surgery

7.3.8.3. Neuro & Orthopedic Surgery

7.3.8.4. Orthopedic Surgery

7.3.8.5. Others

7.3.9. Tenaleaf

7.3.9.1. Gynecological Surgery

7.3.9.2. Abdominal Surgery

7.3.9.3. Neuro & Orthopedic Surgery

7.3.9.4. Orthopedic Surgery

7.3.9.5. Others

7.3.10. Adspray

7.3.10.1. Gynecological Surgery

7.3.10.2. Abdominal Surgery

7.3.10.3. Neuro & Orthopedic Surgery

7.3.10.4. Orthopedic Surgery

7.3.10.5. Others

7.3.11. Others

7.3.11.1. Gynecological Surgery

7.3.11.2. Abdominal Surgery

7.3.11.3. Neuro & Orthopedic Surgery

7.3.11.4. Orthopedic Surgery

7.3.11.5. Others

7.4. Market Attractiveness By Product Type-Application

8. U.S., Europe, and Japan Adhesion Barriers Market Analysis and Forecasts, By Formulation

8.1. Introduction & Definition

8.2. Key Findings / Developments

8.3. Market Value/Volume Forecast By Formulation, 2020 to 2035

8.3.1. Film

8.3.1.1. Seprafilm

8.3.1.2. Gynecare Interceed

8.3.1.3. Adept

8.3.1.4. Duragen Plus

8.3.1.5. MediShield

8.3.1.6. Oxiplex

8.3.1.7. 4DryField PH

8.3.1.8. Hyalobarrier

8.3.1.9. Tenaleaf

8.3.1.10. Adspray

8.3.1.11. Others

8.3.2. Gel

8.3.3. Liquid

8.4. Market Attractiveness By Formulation

9. U.S., Europe, and Japan Adhesion Barriers Market Analysis and Forecasts, By Formulation–Application

9.1. Introduction & Definition

9.2. Key Findings / Developments

9.3. Market Value Forecast By Formulation–Application, 2020 to 2035

9.3.1. Film

9.3.1.1. Gynecological Surgery

9.3.1.2. Abdominal Surgery

9.3.1.3. Neuro & Orthopedic Surgery

9.3.1.4. Orthopedic Surgery

9.3.1.5. Others

9.3.2. Gel

9.3.2.1. Gynecological Surgery

9.3.2.2. Abdominal Surgery

9.3.2.3. Neuro & Orthopedic Surgery

9.3.2.4. Orthopedic Surgery

9.3.2.5. Others

9.3.3. Liquid

9.3.3.1. Gynecological Surgery

9.3.3.2. Abdominal Surgery

9.3.3.3. Neuro & Orthopedic Surgery

9.3.3.4. Orthopedic Surgery

9.3.3.5. Others

9.4. Market Attractiveness By Formulation –Surgery Type

10. U.S., Europe, and Japan Adhesion Barriers Market Analysis and Forecasts, By Application

10.1. Introduction & Definition

10.2. Key Findings / Developments

10.3. Market Value Forecast By Application, 2020 to 2035

10.3.1. Gynecological Surgery

10.3.2. Abdominal Surgery

10.3.3. Neuro & Orthopedic Surgery

10.3.4. Orthopedic Surgery

10.3.5. Others

10.4. Market Attractiveness By Application

11. U.S., Europe, and Japan Adhesion Barriers Market Analysis and Forecasts, By End-user

11.1. Introduction & Definition

11.2. Key Findings / Developments

11.3. Market Value Forecast By End-user, 2020 to 2035

11.3.1. Ambulatory Surgical centers (ASCs)

11.3.2. Hospitals

11.3.3. Specialty Clinics

11.3.4. Others

11.4. Market Attractiveness By End-user

12. U.S., Europe, and Japan Adhesion Barriers Market Analysis and Forecasts, By Region/Country

12.1. Key Findings

12.2. Market Value Forecast By Region/Country

12.2.1. U.S.

12.2.2. Europe

12.2.3. Japan

12.3. Market Attractiveness By Region/Country

13. U.S. Adhesion Barriers Market Analysis and Forecast

13.1. Introduction

13.1.1. Key Findings

13.2. Market Value Forecast By Product Type, 2020 to 2035

13.2.1. Gynecare Interceed

13.2.2. Adept

13.2.3. Duragen Plus

13.2.4. MediShield

13.2.5. Oxiplex

13.2.6. 4DryField PH

13.2.7. Hyalobarrier

13.2.8. Tenaleaf

13.2.9. Adspray

13.2.10. Others

13.3. Market Value Forecast By Product Type-Application, 2020 to 2035

13.3.1. Seprafilm

13.3.1.1. Gynecological Surgery

13.3.1.2. Abdominal Surgery

13.3.1.3. Neuro & Orthopedic Surgery

13.3.1.4. Orthopedic Surgery

13.3.1.5. Others

13.3.2. Gynecare Interceed

13.3.2.1. Gynecological Surgery

13.3.2.2. Abdominal Surgery

13.3.2.3. Neuro & Orthopedic Surgery

13.3.2.4. Orthopedic Surgery

13.3.2.5. Others

13.3.3. Adept

13.3.3.1. Gynecological Surgery

13.3.3.2. Abdominal Surgery

13.3.3.3. Neuro & Orthopedic Surgery

13.3.3.4. Orthopedic Surgery

13.3.3.5. Others

13.3.4. Duragen Plus

13.3.4.1. Gynecological Surgery

13.3.4.2. Abdominal Surgery

13.3.4.3. Neuro & Orthopedic Surgery

13.3.4.4. Orthopedic Surgery

13.3.4.5. Others

13.3.5. MediShield

13.3.5.1. Gynecological Surgery

13.3.5.2. Abdominal Surgery

13.3.5.3. Neuro & Orthopedic Surgery

13.3.5.4. Orthopedic Surgery

13.3.5.5. Others

13.3.6. Oxiplex

13.3.6.1. Gynecological Surgery

13.3.6.2. Abdominal Surgery

13.3.6.3. Neuro & Orthopedic Surgery

13.3.6.4. Orthopedic Surgery

13.3.6.5. Others

13.3.7. 4DryField PH

13.3.7.1. Gynecological Surgery

13.3.7.2. Abdominal Surgery

13.3.7.3. Neuro & Orthopedic Surgery

13.3.7.4. Orthopedic Surgery

13.3.7.5. Others

13.3.8. Hyalobarrier

13.3.8.1. Gynecological Surgery

13.3.8.2. Abdominal Surgery

13.3.8.3. Neuro & Orthopedic Surgery

13.3.8.4. Orthopedic Surgery

13.3.8.5. Others

13.3.9. Tenaleaf

13.3.9.1. Gynecological Surgery

13.3.9.2. Abdominal Surgery

13.3.9.3. Neuro & Orthopedic Surgery

13.3.9.4. Orthopedic Surgery

13.3.9.5. Others

13.3.10. Adspray

13.3.10.1. Gynecological Surgery

13.3.10.2. Abdominal Surgery

13.3.10.3. Neuro & Orthopedic Surgery

13.3.10.4. Orthopedic Surgery

13.3.10.5. Others

13.3.11. Others

13.3.11.1. Gynecological Surgery

13.3.11.2. Abdominal Surgery

13.3.11.3. Neuro & Orthopedic Surgery

13.3.11.4. Orthopedic Surgery

13.3.11.5. Others

13.4. Market Value Forecast By Formulation, 2020 to 2035

13.4.1. Film

13.4.1.1. Seprafilm

13.4.1.2. Gynecare Interceed

13.4.1.3. Adept

13.4.1.4. Duragen Plus

13.4.1.5. MediShield

13.4.1.6. Oxiplex

13.4.1.7. 4DryField PH

13.4.1.8. Hyalobarrier

13.4.1.9. Tenaleaf

13.4.1.10. Adspray

13.4.1.11. Others

13.4.2. Gel

13.4.3. Liquid

13.5. Market Value Forecast By Formulation–Application, 2020 to 2035

13.5.1. Film

13.5.1.1. Gynecological Surgery

13.5.1.2. Abdominal Surgery

13.5.1.3. Neuro & Orthopedic Surgery

13.5.1.4. Orthopedic Surgery

13.5.1.5. Others

13.5.2. Gel

13.5.2.1. Gynecological Surgery

13.5.2.2. Abdominal Surgery

13.5.2.3. Neuro & Orthopedic Surgery

13.5.2.4. Orthopedic Surgery

13.5.2.5. Others

13.5.3. Liquid

13.5.3.1. Gynecological Surgery

13.5.3.2. Abdominal Surgery

13.5.3.3. Neuro & Orthopedic Surgery

13.5.3.4. Orthopedic Surgery

13.5.3.5. Others

13.6. Market Value Forecast By Application, 2020 to 2035

13.6.1. Gynecological Surgery

13.6.2. Abdominal Surgery

13.6.3. Neuro & Orthopedic Surgery

13.6.4. Orthopedic Surgery

13.6.5. Others

13.7. Market Value Forecast By End-user, 2020 to 2035

13.7.1. Ambulatory Surgical centers (ASCs)

13.7.2. Hospitals

13.7.3. Specialty Clinics

13.7.4. Others

13.8. Market Attractiveness Analysis

13.8.1. By Product Type

13.8.2. By Product Type–Application

13.8.3. By Formulation

13.8.4. By Formulation–Application

13.8.5. By Application

13.8.6. By End-user

14. Europe Adhesion Barriers Market Analysis and Forecast

14.1. Introduction

14.1.1. Key Findings

14.2. Market Value Forecast By Product Type, 2020 to 2035

14.2.1. Seprafilm

14.2.2. Gynecare Interceed

14.2.3. Adept

14.2.4. Duragen Plus

14.2.5. MediShield

14.2.6. Oxiplex

14.2.7. 4DryField PH

14.2.8. Hyalobarrier

14.2.9. Tenaleaf

14.2.10. Adspray

14.2.11. Others

14.3. Market Value Forecast By Product Type–Application, 2020 to 2035

14.3.1. Seprafilm

14.3.1.1. Gynecological Surgery

14.3.1.2. Abdominal Surgery

14.3.1.3. Neuro & Orthopedic Surgery

14.3.1.4. Orthopedic Surgery

14.3.1.5. Others

14.3.2. Gynecare Interceed

14.3.2.1. Gynecological Surgery

14.3.2.2. Abdominal Surgery

14.3.2.3. Neuro & Orthopedic Surgery

14.3.2.4. Orthopedic Surgery

14.3.2.5. Others

14.3.3. Adept

14.3.3.1. Gynecological Surgery

14.3.3.2. Abdominal Surgery

14.3.3.3. Neuro & Orthopedic Surgery

14.3.3.4. Orthopedic Surgery

14.3.3.5. Others

14.3.4. Duragen Plus

14.3.4.1. Gynecological Surgery

14.3.4.2. Abdominal Surgery

14.3.4.3. Neuro & Orthopedic Surgery

14.3.4.4. Orthopedic Surgery

14.3.4.5. Others

14.3.5. MediShield

14.3.5.1. Gynecological Surgery

14.3.5.2. Abdominal Surgery

14.3.5.3. Neuro & Orthopedic Surgery

14.3.5.4. Orthopedic Surgery

14.3.5.5. Others

14.3.6. Oxiplex

14.3.6.1. Gynecological Surgery

14.3.6.2. Abdominal Surgery

14.3.6.3. Neuro & Orthopedic Surgery

14.3.6.4. Orthopedic Surgery

14.3.6.5. Others

14.3.7. 4DryField PH

14.3.7.1. Gynecological Surgery

14.3.7.2. Abdominal Surgery

14.3.7.3. Neuro & Orthopedic Surgery

14.3.7.4. Orthopedic Surgery

14.3.7.5. Others

14.3.8. Hyalobarrier

14.3.8.1. Gynecological Surgery

14.3.8.2. Abdominal Surgery

14.3.8.3. Neuro & Orthopedic Surgery

14.3.8.4. Orthopedic Surgery

14.3.8.5. Others

14.3.9. Tenaleaf

14.3.9.1. Gynecological Surgery

14.3.9.2. Abdominal Surgery

14.3.9.3. Neuro & Orthopedic Surgery

14.3.9.4. Orthopedic Surgery

14.3.9.5. Others

14.3.10. Adspray

14.3.10.1. Gynecological Surgery

14.3.10.2. Abdominal Surgery

14.3.10.3. Neuro & Orthopedic Surgery

14.3.10.4. Orthopedic Surgery

14.3.10.5. Others

14.3.11. Others

14.3.11.1. Gynecological Surgery

14.3.11.2. Abdominal Surgery

14.3.11.3. Neuro & Orthopedic Surgery

14.3.11.4. Orthopedic Surgery

14.3.11.5. Others

14.4. Market Value/Volume Forecast By Formulation, 2020 to 2035

14.4.1. Film

14.4.1.1. Seprafilm

14.4.1.2. Gynecare Interceed

14.4.1.3. Adept

14.4.1.4. Duragen Plus

14.4.1.5. MediShield

14.4.1.6. Oxiplex

14.4.1.7. 4DryField PH

14.4.1.8. Hyalobarrier

14.4.1.9. Tenaleaf

14.4.1.10. Adspray

14.4.1.11. Others

14.4.2. Gel

14.4.3. Liquid

14.5. Market Value Forecast By Formulation–Application, 2020 to 2035

14.5.1. Film

14.5.1.1. Gynecological Surgery

14.5.1.2. Abdominal Surgery

14.5.1.3. Neuro & Orthopedic Surgery

14.5.1.4. Orthopedic Surgery

14.5.1.5. Others

14.5.2. Gel

14.5.2.1. Gynecological Surgery

14.5.2.2. Abdominal Surgery

14.5.2.3. Neuro & Orthopedic Surgery

14.5.2.4. Orthopedic Surgery

14.5.2.5. Others

14.5.3. Liquid

14.5.3.1. Gynecological Surgery

14.5.3.2. Abdominal Surgery

14.5.3.3. Neuro & Orthopedic Surgery

14.5.3.4. Orthopedic Surgery

14.5.3.5. Others

14.6. Market Value Forecast By Application, 2020 to 2035

14.6.1. Gynecological Surgery

14.6.2. Abdominal Surgery

14.6.3. Neuro & Orthopedic Surgery

14.6.4. Orthopedic Surgery

14.6.5. Others

14.7. Market Value Forecast By End-user, 2020 to 2035

14.7.1. Ambulatory Surgical centers (ASCs)

14.7.2. Hospitals

14.7.3. Specialty Clinics

14.7.4. Others

14.8. Market Value Forecast By Country , 2020 to 2035

14.8.1. Germany

14.8.2. U.K.

14.8.3. France

14.8.4. Italy

14.8.5. Spain

14.8.6. Russia

14.8.7. Rest of Europe

14.9. Market Attractiveness Analysis

14.9.1. By Product Type

14.9.2. By Product Type-Formulation–Application

14.9.3. By Formulation

14.9.4. By Formulation–Application

14.9.5. By Application

14.9.6. By End-user

14.9.7. By Country/Sub-region

15. Japan Adhesion Barriers Market Analysis and Forecast

15.1. Introduction

15.1.1. Key Findings

15.2. Market Value Forecast By Product Type, 2020 to 2035

15.2.1. Gynecare Interceed

15.2.2. Adept

15.2.3. Duragen Plus

15.2.4. MediShield

15.2.5. Oxiplex

15.2.6. 4DryField PH

15.2.7. Hyalobarrier

15.2.8. Tenaleaf

15.2.9. Adspray

15.2.10. Others

15.3. Market Value Forecast By Product Type-Application, 2020 to 2035

15.3.1. Seprafilm

15.3.1.1. Gynecological Surgery

15.3.1.2. Abdominal Surgery

15.3.1.3. Neuro & Orthopedic Surgery

15.3.1.4. Orthopedic Surgery

15.3.1.5. Others

15.3.2. Gynecare Interceed

15.3.2.1. Gynecological Surgery

15.3.2.2. Abdominal Surgery

15.3.2.3. Neuro & Orthopedic Surgery

15.3.2.4. Orthopedic Surgery

15.3.2.5. Others

15.3.3. Adept

15.3.3.1. Gynecological Surgery

15.3.3.2. Abdominal Surgery

15.3.3.3. Neuro & Orthopedic Surgery

15.3.3.4. Orthopedic Surgery

15.3.3.5. Others

15.3.4. Duragen Plus

15.3.4.1. Gynecological Surgery

15.3.4.2. Abdominal Surgery

15.3.4.3. Neuro & Orthopedic Surgery

15.3.4.4. Orthopedic Surgery

15.3.4.5. Others

15.3.5. MediShield

15.3.5.1. Gynecological Surgery

15.3.5.2. Abdominal Surgery

15.3.5.3. Neuro & Orthopedic Surgery

15.3.5.4. Orthopedic Surgery

15.3.5.5. Others

15.3.6. Oxiplex

15.3.6.1. Gynecological Surgery

15.3.6.2. Abdominal Surgery

15.3.6.3. Neuro & Orthopedic Surgery

15.3.6.4. Orthopedic Surgery

15.3.6.5. Others

15.3.7. 4DryField PH

15.3.7.1. Gynecological Surgery

15.3.7.2. Abdominal Surgery

15.3.7.3. Neuro & Orthopedic Surgery

15.3.7.4. Orthopedic Surgery

15.3.7.5. Others

15.3.8. Hyalobarrier

15.3.8.1. Gynecological Surgery

15.3.8.2. Abdominal Surgery

15.3.8.3. Neuro & Orthopedic Surgery

15.3.8.4. Orthopedic Surgery

15.3.8.5. Others

15.3.9. Tenaleaf

15.3.9.1. Gynecological Surgery

15.3.9.2. Abdominal Surgery

15.3.9.3. Neuro & Orthopedic Surgery

15.3.9.4. Orthopedic Surgery

15.3.9.5. Others

15.3.10. Adspray

15.3.10.1. Gynecological Surgery

15.3.10.2. Abdominal Surgery

15.3.10.3. Neuro & Orthopedic Surgery

15.3.10.4. Orthopedic Surgery

15.3.10.5. Others

15.3.11. Others

15.3.11.1. Gynecological Surgery

15.3.11.2. Abdominal Surgery

15.3.11.3. Neuro & Orthopedic Surgery

15.3.11.4. Orthopedic Surgery

15.3.11.5. Others

15.4. Market Value Forecast By Formulation, 2020 to 2035

15.4.1. Film

15.4.1.1. Seprafilm

15.4.1.2. Gynecare Interceed

15.4.1.3. Adept

15.4.1.4. Duragen Plus

15.4.1.5. MediShield

15.4.1.6. Oxiplex

15.4.1.7. 4DryField PH

15.4.1.8. Hyalobarrier

15.4.1.9. Tenaleaf

15.4.1.10. Adspray

15.4.1.11. Others

15.4.2. Gel

15.4.3. Liquid

15.5. Market Value Forecast By Formulation–Application, 2020 to 2035

15.5.1. Film

15.5.1.1. Gynecological Surgery

15.5.1.2. Abdominal Surgery

15.5.1.3. Neuro & Orthopedic Surgery

15.5.1.4. Orthopedic Surgery

15.5.1.5. Others

15.5.2. Gel

15.5.2.1. Gynecological Surgery

15.5.2.2. Abdominal Surgery

15.5.2.3. Neuro & Orthopedic Surgery

15.5.2.4. Orthopedic Surgery

15.5.2.5. Others

15.5.3. Liquid

15.5.3.1. Gynecological Surgery

15.5.3.2. Abdominal Surgery

15.5.3.3. Neuro & Orthopedic Surgery

15.5.3.4. Orthopedic Surgery

15.5.3.5. Others

15.6. Market Value Forecast By Application, 2020 to 2035

15.6.1. Gynecological Surgery

15.6.2. Abdominal Surgery

15.6.3. Neuro & Orthopedic Surgery

15.6.4. Orthopedic Surgery

15.6.5. Others

15.7. Market Value Forecast By End-user, 2020 to 2035

15.7.1. Ambulatory Surgical centers (ASCs)

15.7.2. Hospitals

15.7.3. Specialty Clinics

15.7.4. Others

15.8. Market Attractiveness Analysis

15.8.1. By Product Type

15.8.2. By Product Type–Application

15.8.3. By Formulation

15.8.4. By Formulation–Application

15.8.5. By Application

15.8.6. By End-user

16. Competition Landscape

16.1. Market Player – Competition Matrix (By Tier and Size of companies)

16.2. Market Share Analysis By Company (2024)

16.3. Company Profiles

16.3.1. Baxter International Inc.

16.3.1.1. Company Overview

16.3.1.2. Financial Overview

16.3.1.3. Product Portfolio

16.3.1.4. Business Strategies

16.3.1.5. Recent Developments

16.3.2. Terumo Medical Corporation

16.3.2.1. Company Overview

16.3.2.2. Financial Overview

16.3.2.3. Product Portfolio

16.3.2.4. Business Strategies

16.3.2.5. Recent Developments

16.3.3. Medtronic plc

16.3.3.1. Company Overview

16.3.3.2. Financial Overview

16.3.3.3. Product Portfolio

16.3.3.4. Business Strategies

16.3.3.5. Recent Developments

16.3.4. Johnson & Johnson Services, Inc.

16.3.4.1. Company Overview

16.3.4.2. Financial Overview

16.3.4.3. Product Portfolio

16.3.4.4. Business Strategies

16.3.4.5. Recent Developments

16.3.5. Integra LifeScience

16.3.5.1. Company Overview

16.3.5.2. Financial Overview

16.3.5.3. Product Portfolio

16.3.5.4. Business Strategies

16.3.5.5. Recent Developments

16.3.6. PlantTec Medical GmbH

16.3.6.1. Company Overview

16.3.6.2. Financial Overview

16.3.6.3. Product Portfolio

16.3.6.4. Business Strategies

16.3.6.5. Recent Developments

16.3.7. Fziomed, Inc.

16.3.7.1. Company Overview

16.3.7.2. Financial Overview

16.3.7.3. Product Portfolio

16.3.7.4. Business Strategies

16.3.7.5. Recent Developments

16.3.8. Anika Therapeutics, Inc.

16.3.8.1. Company Overview

16.3.8.2. Financial Overview

16.3.8.3. Product Portfolio

16.3.8.4. Business Strategies

16.3.8.5. Recent Developments

16.3.9. Kyeron

16.3.9.1. Company Overview

16.3.9.2. Financial Overview

16.3.9.3. Product Portfolio

16.3.9.4. Business Strategies

16.3.9.5. Recent Developments

16.3.10. BioRegen Biomedical (Changzhou) Co., Ltd

16.3.10.1. Company Overview

16.3.10.2. Financial Overview

16.3.10.3. Product Portfolio

16.3.10.4. Business Strategies

16.3.10.5. Recent Developments

16.3.11. DALIM TISSEN Co., Ltd.

16.3.11.1. Company Overview

16.3.11.2. Financial Overview

16.3.11.3. Product Portfolio

16.3.11.4. Business Strategies

16.3.11.5. Recent Developments

16.3.12. Gunze Medical Co., Ltd.

16.3.12.1. Company Overview

16.3.12.2. Financial Overview

16.3.12.3. Product Portfolio

16.3.12.4. Business Strategies

16.3.12.5. Recent Developments

List of Tables

Table 01: U.S., Europe, and Japan Adhesion Barriers Market Value (US$ Bn) Forecast, By Product Type, 2020 to 2035

Table 02: U.S., Europe, and Japan Adhesion Barriers Market Value (US$ Bn) Forecast, By Product Type-Application, 2020 to 2035

Table 03: U.S., Europe, and Japan Adhesion Barriers Market Value (US$ Bn) Forecast, By Seprafilm, 2020 to 2035

Table 04: U.S., Europe, and Japan Adhesion Barriers Market Value (US$ Bn) Forecast, By Gynecare Interceed, 2020 to 2035

Table 05: U.S., Europe, and Japan Adhesion Barriers Market Value (US$ Bn) Forecast, By Adept, 2020 to 2035

Table 06: U.S., Europe, and Japan Adhesion Barriers Market Value (US$ Bn) Forecast, By Duragen Plus, 2020 to 2035

Table 07: U.S., Europe, and Japan Adhesion Barriers Market Value (US$ Bn) Forecast, By MediShield, 2020 to 2035

Table 08: U.S., Europe, and Japan Adhesion Barriers Market Value (US$ Bn) Forecast, By Oxiplex, 2020 to 2035

Table 09: U.S., Europe, and Japan Adhesion Barriers Market Value (US$ Bn) Forecast, By 4DryField PH, 2020 to 2035

Table 10: U.S., Europe, and Japan Adhesion Barriers Market Value (US$ Bn) Forecast, By Hyalobarrier, 2020 to 2035

Table 11: U.S., Europe, and Japan Adhesion Barriers Market Value (US$ Bn) Forecast, By Tenaleaf, 2020 to 2035

Table 12: U.S., Europe, and Japan Adhesion Barriers Market Value (US$ Bn) Forecast, By Adspray, 2020 to 2035

Table 13: U.S., Europe, and Japan Adhesion Barriers Market Value (US$ Bn) Forecast, By Others, 2020 to 2035

Table 14: U.S., Europe, and Japan Adhesion Barriers Market Value (US$ Bn) Forecast, By Formulation, 2020 to 2035

Table 15: U.S., Europe, and Japan Adhesion Barriers Market Value (US$ Bn) Forecast, By Film, 2020 to 2035

Table 16: U.S., Europe, and Japan Adhesion Barriers Market Volume (Sq.m) Forecast, By Film, 2020 to 2035

Table 17: U.S., Europe, and Japan Adhesion Barriers Market Value (US$ Bn) Forecast, By Formulation-Application, 2020 to 2035

Table 18: U.S., Europe, and Japan Adhesion Barriers Market Value (US$ Bn) Forecast, By Film, 2020 to 2035

Table 19: U.S., Europe, and Japan Adhesion Barriers Market Value (US$ Bn) Forecast, By Gel, 2020 to 2035

Table 20: U.S., Europe, and Japan Adhesion Barriers Market Value (US$ Bn) Forecast, By Liquid, 2020 to 2035

Table 21: U.S., Europe, and Japan Adhesion Barriers Market Value (US$ Bn) Forecast, By Application, 2020 to 2035

Table 22: U.S., Europe, and Japan Adhesion Barriers Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035

Table 23: U.S., Europe, and Japan Adhesion Barriers Market Value (US$ Bn) Forecast, By Region/Country, 2020 to 2035

Table 24: U.S. Adhesion Barriers Market Value (US$ Bn) Forecast, By Product Type, 2020 to 2035

Table 25: U.S. Adhesion Barriers Market Value (US$ Bn) Forecast, By Product Type-Application, 2020 to 2035

Table 26: U.S. Adhesion Barriers Market Value (US$ Bn) Forecast, By Seprafilm, 2020 to 2035

Table 27: U.S. Adhesion Barriers Market Value (US$ Bn) Forecast, By Gynecare Interceed, 2020 to 2035

Table 28: U.S. Adhesion Barriers Market Value (US$ Bn) Forecast, By Adept, 2020 to 2035

Table 29: U.S. Adhesion Barriers Market Value (US$ Bn) Forecast, By Duragen Plus, 2020 to 2035

Table 30: U.S. Adhesion Barriers Market Value (US$ Bn) Forecast, By Others, 2020 to 2035

Table 31: U.S. Adhesion Barriers Market Value (US$ Bn) Forecast, By Formulation, 2020 to 2035

Table 32: U.S. Adhesion Barriers Market Value (US$ Bn) Forecast, By Film, 2020 to 2035

Table 33: U.S. Adhesion Barriers Market Volume (Sq. M) Forecast, By Film, 2020 to 2035

Table 34: U.S. Adhesion Barriers Market Value (US$ Bn) Forecast, By Formulation-Application, 2020 to 2035

Table 35: U.S. Adhesion Barriers Market Value (US$ Bn) Forecast, By Film, 2020 to 2035

Table 36: U.S. Adhesion Barriers Market Value (US$ Bn) Forecast, By Gel, 2020 to 2035

Table 37: U.S. Adhesion Barriers Market Value (US$ Bn) Forecast, By Liquid, 2020 to 2035

Table 38: U.S. Adhesion Barriers Market Value (US$ Bn) Forecast, By Application, 2020 to 2035

Table 39: U.S. Adhesion Barriers Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035

Table 40: Europe - Adhesion Barriers Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035

Table 41: Europe Adhesion Barriers Market Value (US$ Bn) Forecast, By Product Type, 2020 to 2035

Table 42: Europe Adhesion Barriers Market Value (US$ Bn) Forecast, By Product Type-Application, 2020 to 2035

Table 43: Europe Adhesion Barriers Market Value (US$ Bn) Forecast, By Seprafilm, 2020 to 2035

Table 44: Europe Adhesion Barriers Market Value (US$ Bn) Forecast, By Gynecare Interceed, 2020 to 2035

Table 45: Europe Adhesion Barriers Market Value (US$ Bn) Forecast, By Adept, 2020 to 2035

Table 46: Europe Adhesion Barriers Market Value (US$ Bn) Forecast, By Duragen Plus, 2020 to 2035

Table 47: Europe Adhesion Barriers Market Value (US$ Bn) Forecast, By MediShield, 2020 to 2035

Table 48: Europe Adhesion Barriers Market Value (US$ Bn) Forecast, By Oxiplex, 2020 to 2035

Table 49: Europe Adhesion Barriers Market Value (US$ Bn) Forecast, By 4DryField PH, 2020 to 2035

Table 50: Europe Adhesion Barriers Market Value (US$ Bn) Forecast, By Hyalobarrier, 2020 to 2035

Table 51: Europe Adhesion Barriers Market Value (US$ Bn) Forecast, By Others, 2020 to 2035

Table 52: Europe Adhesion Barriers Market Value (US$ Bn) Forecast, By Formulation, 2020 to 2035

Table 53: Europe Adhesion Barriers Market Value (US$ Bn) Forecast, By Film, 2020 to 2035

Table 54: Europe Adhesion Barriers Market Volume (Sq. M) Forecast, By Film, 2020 to 2035

Table 55: Europe Adhesion Barriers Market Value (US$ Bn) Forecast, By Formulation-Application, 2020 to 2035

Table 56: Europe Adhesion Barriers Market Value (US$ Bn) Forecast, By Film, 2020 to 2035

Table 57: Europe Adhesion Barriers Market Value (US$ Bn) Forecast, By Gel, 2020 to 2035

Table 58: Europe Adhesion Barriers Market Value (US$ Bn) Forecast, By Liquid, 2020 to 2035

Table 59: Europe Adhesion Barriers Market Value (US$ Bn) Forecast, By Application, 2020 to 2035

Table 60: Europe Adhesion Barriers Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035

Table 61: Japan Adhesion Barriers Market Value (US$ Bn) Forecast, By Product Type, 2020 to 2035

Table 62: Japan Adhesion Barriers Market Value (US$ Bn) Forecast, By Product Type-Application, 2020 to 2035

Table 63: Japan Adhesion Barriers Market Value (US$ Bn) Forecast, By Seprafilm, 2020 to 2035

Table 64: Japan Adhesion Barriers Market Value (US$ Bn) Forecast, By Gynecare Interceed, 2020 to 2035

Table 65: Japan Adhesion Barriers Market Value (US$ Bn) Forecast, By Tenaleaf, 2020 to 2035

Table 66: Japan Adhesion Barriers Market Value (US$ Bn) Forecast, By Adspray, 2020 to 2035

Table 67: Japan Adhesion Barriers Market Value (US$ Bn) Forecast, By Others, 2020 to 2035

Table 68: Japan Adhesion Barriers Market Value (US$ Bn) Forecast, By Formulation, 2020 to 2035

Table 69: Japan Adhesion Barriers Market Value (US$ Bn) Forecast, By Film, 2020 to 2035

Table 70: Japan Adhesion Barriers Market Volume (Sq. M) Forecast, By Film, 2020 to 2035

Table 71: Japan Adhesion Barriers Market Value (US$ Bn) Forecast, By Formulation-Application, 2020 to 2035

Table 72: Japan Adhesion Barriers Market Value (US$ Bn) Forecast, By Film, 2020 to 2035

Table 73: Japan Adhesion Barriers Market Value (US$ Bn) Forecast, By Gel, 2020 to 2035

Table 74: Japan Adhesion Barriers Market Value (US$ Bn) Forecast, By Liquid, 2020 to 2035

Table 75: Japan Adhesion Barriers Market Value (US$ Bn) Forecast, By Application, 2020 to 2035

Table 76: Japan Adhesion Barriers Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035

List of Figures

Figure 01: U.S., Europe, and Japan Adhesion Barriers Market Value Share Analysis, By Product Type, 2024 and 2035

Figure 02: U.S., Europe, and Japan Adhesion Barriers Market Attractiveness Analysis, By Product Type, 2025 to 2035

Figure 03: U.S., Europe, and Japan Adhesion Barriers Market Revenue (US$ Mn), by Seprafilm, 2020 to 2035

Figure 04: U.S., Europe, and Japan Adhesion Barriers Market Revenue (US$ Mn), by Gynecare Interceed, 2020 to 2035

Figure 05: U.S., Europe, and Japan Adhesion Barriers Market Revenue (US$ Mn), by Adept, 2020 to 2035

Figure 06: U.S., Europe, and Japan Adhesion Barriers Market Revenue (US$ Mn), by Duragen Plus, 2020 to 2035

Figure 07: U.S., Europe, and Japan Adhesion Barriers Market Revenue (US$ Mn), by MediShield, 2020 to 2035

Figure 08: U.S., Europe, and Japan Adhesion Barriers Market Revenue (US$ Mn), by Oxiplex, 2020 to 2035

Figure 09: U.S., Europe, and Japan Adhesion Barriers Market Revenue (US$ Mn), by 4DryField PH, 2020 to 2035

Figure 10: U.S., Europe, and Japan Adhesion Barriers Market Revenue (US$ Mn), by Hyalobarrier, 2020 to 2035

Figure 11: U.S., Europe, and Japan Adhesion Barriers Market Revenue (US$ Mn), by Tenaleaf, 2020 to 2035

Figure 12: U.S., Europe, and Japan Adhesion Barriers Market Revenue (US$ Mn), by Adspray, 2020 to 2035

Figure 13: U.S., Europe, and Japan Adhesion Barriers Market Revenue (US$ Mn), by Others, 2020 to 2035

Figure 14: U.S., Europe, and Japan Adhesion Barriers Market Value Share Analysis, By Product Type-Application, 2024 and 2035

Figure 15: U.S., Europe, and Japan Adhesion Barriers Market Attractiveness Analysis, By Product Type-Application, 2025 to 2035

Figure 16: U.S., Europe, and Japan Adhesion Barriers Market Revenue (US$ Mn), by Seprafilm, 2020 to 2035

Figure 17: U.S., Europe, and Japan Adhesion Barriers Market Revenue (US$ Mn), by Gynecare Interceed, 2020 to 2035

Figure 18: U.S., Europe, and Japan Adhesion Barriers Market Revenue (US$ Mn), by Adept, 2020 to 2035

Figure 19: U.S., Europe, and Japan Adhesion Barriers Market Revenue (US$ Mn), by Duragen Plus, 2020 to 2035

Figure 20: U.S., Europe, and Japan Adhesion Barriers Market Revenue (US$ Mn), by MediShield, 2020 to 2035

Figure 21: U.S., Europe, and Japan Adhesion Barriers Market Revenue (US$ Mn), by Oxiplex, 2020 to 2035

Figure 22: U.S., Europe, and Japan Adhesion Barriers Market Revenue (US$ Mn), by 4DryField PH, 2020 to 2035

Figure 23: U.S., Europe, and Japan Adhesion Barriers Market Revenue (US$ Mn), by Hyalobarrier, 2020 to 2035

Figure 24: U.S., Europe, and Japan Adhesion Barriers Market Revenue (US$ Mn), by Tenaleaf, 2020 to 2035

Figure 25: U.S., Europe, and Japan Adhesion Barriers Market Revenue (US$ Mn), by Adspray, 2020 to 2035

Figure 26: U.S., Europe, and Japan Adhesion Barriers Market Revenue (US$ Mn), by Others, 2020 to 2035

Figure 27: U.S., Europe, and Japan Adhesion Barriers Market Value Share Analysis, By Formulation, 2024 and 2035

Figure 28: U.S., Europe, and Japan Adhesion Barriers Market Attractiveness Analysis, By Formulation, 2025 to 2035

Figure 29: U.S., Europe, and Japan Adhesion Barriers Market Revenue (US$ Mn), by Film, 2020 to 2035

Figure 30: U.S., Europe, and Japan Adhesion Barriers Market Revenue (US$ Mn), by Gel, 2020 to 2035

Figure 31: U.S., Europe, and Japan Adhesion Barriers Market Revenue (US$ Mn), by Liquid, 2020 to 2035

Figure 32: U.S., Europe, and Japan Adhesion Barriers Market Value Share Analysis, By Formulation-Application, 2024 and 2035

Figure 33: U.S., Europe, and Japan Adhesion Barriers Market Attractiveness Analysis, By Formulation-Application, 2025 to 2035

Figure 34: U.S., Europe, and Japan Adhesion Barriers Market Revenue (US$ Mn), by Film, 2020 to 2035

Figure 35: U.S., Europe, and Japan Adhesion Barriers Market Revenue (US$ Mn), by Gel, 2020 to 2035

Figure 36: U.S., Europe, and Japan Adhesion Barriers Market Revenue (US$ Mn), by Liquid, 2020 to 2035

Figure 37: U.S., Europe, and Japan Adhesion Barriers Market Value Share Analysis, By Application, 2024 and 2035

Figure 38: U.S., Europe, and Japan Adhesion Barriers Market Attractiveness Analysis, By Application, 2025 to 2035

Figure 39: U.S., Europe, and Japan Adhesion Barriers Market Revenue (US$ Mn), by Gynecological Surgery, 2020 to 2035

Figure 40: U.S., Europe, and Japan Adhesion Barriers Market Revenue (US$ Mn), by Abdominal Surgery, 2020 to 2035

Figure 41: U.S., Europe, and Japan Adhesion Barriers Market Revenue (US$ Mn), by Neuro Surgery, 2020 to 2035

Figure 42: U.S., Europe, and Japan Adhesion Barriers Market Revenue (US$ Mn), by Orthopedic Surgery, 2020 to 2035

Figure 43: U.S., Europe, and Japan Adhesion Barriers Market Revenue (US$ Mn), by Others, 2020 to 2035

Figure 44: U.S., Europe, and Japan Adhesion Barriers Market Value Share Analysis, By End-user, 2024 and 2035

Figure 45: U.S., Europe, and Japan Adhesion Barriers Market Attractiveness Analysis, By End-user, 2025 to 2035

Figure 46: U.S., Europe, and Japan Adhesion Barriers Market Revenue (US$ Mn), by Ambulatory Surgical centers (ASCs), 2020 to 2035

Figure 47: U.S., Europe, and Japan Adhesion Barriers Market Revenue (US$ Mn), by Hospitals, 2020 to 2035

Figure 48: U.S., Europe, and Japan Adhesion Barriers Market Revenue (US$ Mn), by Specialty Clinics, 2020 to 2035

Figure 49: U.S., Europe, and Japan Adhesion Barriers Market Revenue (US$ Mn), by Others, 2020 to 2035

Figure 50: U.S., Europe, and Japan Adhesion Barriers Market Value Share Analysis, By Region/Country, 2024 and 2035

Figure 51: U.S., Europe, and Japan Adhesion Barriers Market Attractiveness Analysis, By Region/Country, 2025 to 2035

Figure 52: U.S. - Adhesion Barriers Market Value (US$ Mn) Forecast, 2020 to 2035

Figure 53: U.S. Adhesion Barriers Market Value Share Analysis, By Product Type, 2024 and 2035

Figure 54: U.S. Adhesion Barriers Market Attractiveness Analysis, By Product Type, 2025 to 2035

Figure 55: U.S. Adhesion Barriers Market Value Share Analysis, By Product Type-Application, 2024 and 2035

Figure 56: U.S. Adhesion Barriers Market Attractiveness Analysis, By Product Type-Application, 2025 to 2035

Figure 57: U.S. Adhesion Barriers Market Value Share Analysis, By Formulation, 2024 and 2035

Figure 58: U.S. Adhesion Barriers Market Attractiveness Analysis, By Formulation, 2025 to 2035

Figure 59: U.S. Adhesion Barriers Market Value Share Analysis, By Formulation-Application, 2024 and 2035

Figure 60: U.S. Adhesion Barriers Market Attractiveness Analysis, By Formulation-Application, 2025 to 2035

Figure 61: U.S. Adhesion Barriers Market Value Share Analysis, By Application, 2024 and 2035

Figure 62: U.S. Adhesion Barriers Market Attractiveness Analysis, By Application, 2025 to 2035

Figure 63: U.S. Adhesion Barriers Market Value Share Analysis, By End-user, 2024 and 2035

Figure 64: U.S. Adhesion Barriers Market Attractiveness Analysis, By End-user, 2025 to 2035

Figure 65: Europe - Adhesion Barriers Market Value (US$ Mn) Forecast, 2020 to 2035

Figure 66: Europe - Adhesion Barriers Market Value Share Analysis, by Country / Sub-region, 2024 and 2035

Figure 67: Europe - Adhesion Barriers Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035

Figure 68: Europe Adhesion Barriers Market Value Share Analysis, By Product Type, 2024 and 2035

Figure 69: Europe Adhesion Barriers Market Attractiveness Analysis, By Product Type, 2025 to 2035

Figure 70: Europe Adhesion Barriers Market Value Share Analysis, By Product Type-Application, 2024 and 2035

Figure 71: Europe Adhesion Barriers Market Attractiveness Analysis, By Product Type-Application, 2025 to 2035

Figure 72: Europe Adhesion Barriers Market Value Share Analysis, By Formulation, 2024 and 2035

Figure 73: Europe Adhesion Barriers Market Attractiveness Analysis, By Formulation, 2025 to 2035

Figure 74: Europe Adhesion Barriers Market Value Share Analysis, By Formulation-Application, 2024 and 2035

Figure 75: Europe Adhesion Barriers Market Attractiveness Analysis, By Formulation-Application, 2025 to 2035

Figure 76: Europe Adhesion Barriers Market Value Share Analysis, By Application, 2024 and 2035

Figure 77: Europe Adhesion Barriers Market Attractiveness Analysis, By Application, 2025 to 2035

Figure 78: Europe Adhesion Barriers Market Value Share Analysis, By End-user, 2024 and 2035

Figure 79: Europe Adhesion Barriers Market Attractiveness Analysis, By End-user, 2025 to 2035

Figure 80: Japan - Adhesion Barriers Market Value (US$ Mn) Forecast, 2020 to 2035

Figure 81: Japan Adhesion Barriers Market Value Share Analysis, By Product Type, 2024 and 2035

Figure 82: Japan Adhesion Barriers Market Attractiveness Analysis, By Product Type, 2025 to 2035

Figure 83: Japan Adhesion Barriers Market Value Share Analysis, By Product Type-Application, 2024 and 2035

Figure 84: Japan Adhesion Barriers Market Attractiveness Analysis, By Product Type-Application, 2025 to 2035

Figure 85: Japan Adhesion Barriers Market Value Share Analysis, By Formulation, 2024 and 2035

Figure 86: Japan Adhesion Barriers Market Attractiveness Analysis, By Formulation, 2025 to 2035

Figure 87: Japan Adhesion Barriers Market Value Share Analysis, By Formulation-Application, 2024 and 2035

Figure 88: Japan Adhesion Barriers Market Attractiveness Analysis, By Formulation-Application, 2025 to 2035

Figure 89: Japan Adhesion Barriers Market Value Share Analysis, By Application, 2024 and 2035

Figure 90: Japan Adhesion Barriers Market Attractiveness Analysis, By Application, 2025 to 2035

Figure 91: Japan Adhesion Barriers Market Value Share Analysis, By End-user, 2024 and 2035

Figure 92: Japan Adhesion Barriers Market Attractiveness Analysis, By End-user, 2025 to 2035

TMRGL86742
July 2025
274 Pages
PPT, Excel, PDF

Get FREE Sample

- Get Started -

Get insights that lead to new growth opportunities

Buy Now

Get answers to your queries on this report from our experts

Ask an Expert

- Want to customize this report? -

We offer 100% Free Customization at the time of purchase

Get Free Customization

An adaptive Approach to Modern Day Research needs

Analyze Methodology